HealthStream (HSTM) Expected to Post Quarterly Earnings on Monday

HealthStream (NASDAQ:HSTM) is projected to release its Q2 2026 results after the market closes on Monday, August 3rd. Analysts expect the company to post earnings of $0.17 per share and revenue of $80.8310 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Tuesday, August 4, 2026 at 9:00 AM ET.

HealthStream (NASDAQ:HSTM) last issued its quarterly earnings data on Monday, May 4th. The technology company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.04. HealthStream had a net margin of 6.39% and a return on equity of 6.47%. The firm had revenue of $81.20 million for the quarter, compared to analyst estimates of $79.68 million. On average, analysts expect HealthStream to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

HealthStream Price Performance

NASDAQ HSTM opened at $27.14 on Monday. The stock has a market capitalization of $793.03 million, a P/E ratio of 40.51, a PEG ratio of 3.08 and a beta of 0.45. The firm’s 50-day moving average is $26.34 and its two-hundred day moving average is $23.10. HealthStream has a 12 month low of $19.50 and a 12 month high of $30.00.

HealthStream Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Monday, May 18th were given a dividend of $0.035 per share. The ex-dividend date of this dividend was Monday, May 18th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.5%. HealthStream’s dividend payout ratio (DPR) is presently 20.90%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Canaccord Genuity Group boosted their target price on HealthStream from $24.00 to $27.00 and gave the company a “hold” rating in a research report on Tuesday, July 21st. Weiss Ratings upgraded HealthStream from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 23rd. Finally, Wall Street Zen raised HealthStream from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $27.00.

Insider Activity at HealthStream

In other HealthStream news, Director Linda Rebrovick sold 6,000 shares of the stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $29.00, for a total transaction of $174,000.00. Following the sale, the director directly owned 51,329 shares in the company, valued at $1,488,541. This represents a 10.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Kevin P. O’hara sold 3,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $24.08, for a total transaction of $72,240.00. Following the completion of the transaction, the executive vice president directly owned 20,982 shares of the company’s stock, valued at $505,246.56. This represents a 12.51% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 11,000 shares of company stock valued at $296,240. Insiders own 20.40% of the company’s stock.

Institutional Investors Weigh In On HealthStream

Hedge funds have recently bought and sold shares of the stock. JPMorgan Chase & Co. lifted its position in HealthStream by 302.0% during the 2nd quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company’s stock worth $6,860,000 after acquiring an additional 186,231 shares during the period. Qube Research & Technologies Ltd increased its holdings in shares of HealthStream by 77.3% in the second quarter. Qube Research & Technologies Ltd now owns 251,953 shares of the technology company’s stock valued at $6,972,000 after purchasing an additional 109,883 shares during the period. Numerai GP LLC purchased a new stake in shares of HealthStream during the third quarter worth approximately $1,911,000. Jane Street Group LLC lifted its holdings in shares of HealthStream by 180.4% during the fourth quarter. Jane Street Group LLC now owns 96,887 shares of the technology company’s stock worth $2,235,000 after purchasing an additional 62,339 shares during the period. Finally, Inspire Investing LLC raised its position in HealthStream by 352.3% during the 4th quarter. Inspire Investing LLC now owns 72,522 shares of the technology company’s stock worth $1,673,000 after buying an additional 56,487 shares during the last quarter. Institutional investors and hedge funds own 69.58% of the company’s stock.

HealthStream Company Profile

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.